Bradová V, Smíd F, Ulrich-Bott B, Roggendorf W, Paton B C, Harzer K
Hlava Institute of Pathology, 1st Faculty of Medicine, Charles University, Prague, Czech Republic.
Hum Genet. 1993 Sep;92(2):143-52. doi: 10.1007/BF00219682.
Sphingolipid activator protein (SAP) deficiency, previously described in two sibs and shown to be caused by the absence of the common saposin precursor (prosaposin), was further characterized by biochemical lipid and enzyme studies and by ultrastructural analysis. The 20-week-old fetal sib had increased concentrations of neutral glycolipids, including mono-, di-, tri- and tetrahexosylceramide, in liver, kidney and cultured skin fibroblasts compared with the controls. Glucosylceramide and lactosylceramide were particularly elevated. The kidney of the affected fetus showed additional increases in the concentration of sulphatide, galactosylceramide and digalactosylceramide. Free ceramide was stored in the liver and kidney, and GM3 and GM2 gangliosides were elevated in the liver, but not the brain, of the fetus. Phospholipids, however, were normal in the affected fetus. In the liver biopsy of the propositus, who later died at 16 weeks of age, only a few lipids could be studied. Glucosylceramide, dihexosylceramide and ceramide were elevated in agreement with our previous study. Enzyme studies were undertaken using detergent-free liposomal substrate preparations and fibroblast extracts. The sibs' beta-glucocerebrosidase and beta-galactocerebrosidase activities were clearly reduced, but their sphingomyelinase activities were normal. The normal activity of the latter enzyme and the almost normal tissue concentration of sphingomyelin in prosaposin deficiency suggest that the prosaposin-derived SAPs are not required for sphingomyelinase activity in vivo. In keeping with the biochemical findings, skin biopsies from the sibs showed massive lysosomal storage with a vesicular and membranous ultrastructure. The function of SAPs in sphingolipid degradation and the role of SAPs for enzyme activity in vitro are discussed. In addition, the similarity in neutral glycolipid accumulations in Niemann-Pick disease type C and in prosaposin deficiency are noted. The phenotype of the prosaposin deficient sibs resembled acute neuronopathic (type 2) Gaucher disease more than Farber disease in several aspects, but their genotype was unique.
鞘脂激活蛋白(SAP)缺乏症,此前在两名同胞中被描述,并被证明是由于缺乏常见的鞘脂激活蛋白原(prosaposin)所致,通过生化脂质和酶学研究以及超微结构分析对其进行了进一步表征。与对照组相比,这名20周大的胎儿同胞的肝脏、肾脏和培养的皮肤成纤维细胞中中性糖脂浓度升高,包括单己糖神经酰胺、二己糖神经酰胺、三己糖神经酰胺和四己糖神经酰胺。葡萄糖神经酰胺和乳糖神经酰胺尤其升高。患病胎儿的肾脏中硫脂、半乳糖神经酰胺和二半乳糖神经酰胺的浓度进一步升高。游离神经酰胺储存在肝脏和肾脏中,胎儿的肝脏中GM3和GM2神经节苷脂升高,但大脑中未升高。然而,患病胎儿的磷脂正常。在后来于16周龄死亡的先证者的肝脏活检中,仅能研究少数几种脂质。葡萄糖神经酰胺、二己糖神经酰胺和神经酰胺升高,与我们之前的研究一致。使用无去污剂脂质体制剂和成纤维细胞提取物进行了酶学研究。这两名同胞的β-葡萄糖脑苷脂酶和β-半乳糖脑苷脂酶活性明显降低,但他们的鞘磷脂酶活性正常。后一种酶的正常活性以及鞘脂激活蛋白原缺乏症中鞘磷脂几乎正常的组织浓度表明,体内鞘磷脂酶活性不需要鞘脂激活蛋白原衍生的SAPs。与生化研究结果一致,这两名同胞的皮肤活检显示大量溶酶体储存,具有泡状和膜状超微结构。讨论了SAPs在鞘脂降解中的功能以及SAPs在体外酶活性中的作用。此外,还指出了尼曼-匹克病C型和鞘脂激活蛋白原缺乏症中中性糖脂积累的相似性。鞘脂激活蛋白原缺乏的同胞的表型在几个方面比法伯病更类似于急性神经元病性(2型)戈谢病,但其基因型是独特的。